1.
J Formos Med Assoc
; 120(12): 2186-2190, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1198883
ABSTRACT
We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.